NasdaqCM - Nasdaq Real Time Price USD

Aurora Cannabis Inc. (ACB)

Compare
4.4200
-0.2400
(-5.15%)
At close: January 8 at 4:00:01 PM EST
4.5396
+0.12
+(2.71%)
After hours: 7:38:48 PM EST
Loading Chart for ACB
DELL
  • Previous Close 4.6600
  • Open 4.6100
  • Bid --
  • Ask --
  • Day's Range 4.3300 - 4.6128
  • 52 Week Range 2.8400 - 9.3500
  • Volume 627,181
  • Avg. Volume 943,269
  • Market Cap (intraday) 244.097M
  • Beta (5Y Monthly) 2.70
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4700
  • Earnings Date Feb 6, 2025 - Feb 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

www.auroramj.com

1,073

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ACB

View More

Performance Overview: ACB

Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACB
5.24%
S&P/TSX Composite index
1.84%

1-Year Return

ACB
7.34%
S&P/TSX Composite index
18.97%

3-Year Return

ACB
91.98%
S&P/TSX Composite index
18.92%

5-Year Return

ACB
97.88%
S&P/TSX Composite index
46.05%

Compare To: ACB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACB

View More

Valuation Measures

As of 1/8/2025
  • Market Cap

    244.10M

  • Enterprise Value

    255.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.17

  • Price/Book (mrq)

    0.64

  • Enterprise Value/Revenue

    1.23

  • Enterprise Value/EBITDA

    97.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -14.71%

  • Return on Assets (ttm)

    -1.24%

  • Return on Equity (ttm)

    -5.79%

  • Revenue (ttm)

    296.99M

  • Net Income Avi to Common (ttm)

    -29.77M

  • Diluted EPS (ttm)

    -0.4700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    84.92M

  • Total Debt/Equity (mrq)

    17.32%

  • Levered Free Cash Flow (ttm)

    -84.08M

Research Analysis: ACB

View More

People Also Watch